
CEO spotlight: Kevin Cook
A conversation with Kevin Cook about CDMO-sponsor partnerships and outsourcing Kevin Cook, CEO at Sterling Pharma Solutions recently spoke with…
Sterling’s facility in Cary, North Carolina provides us with a physical presence close to the pharmaceutical and biotech hub, Research Triangle Park.
We deliver expert chemistry solutions for pre-clinical and early phase clinical supply from the facility and can cater for volumes from millilitres up to 100-litre batches, ideal for small volume products or products in the early stages of clinical trials.
Our facility features cGMP API manufacturing capabilities and allows us to produce high value, low volume APIs including high barrier to entry compounds that are generally difficult to manufacture.
In this video our President US Operations, Mat Minardi, gives an overview of the US facility and the team’s expertise.
For more information, or to speak to a member of the Sterling team, please get in touch.
A conversation with Kevin Cook about CDMO-sponsor partnerships and outsourcing Kevin Cook, CEO at Sterling Pharma Solutions recently spoke with…
View our infographic to explore the growth of highly potent molecules and key considerations to unlock their full potential in…
There is a growing demand for hazardous chemistry techniques for synthetic manufacturing processes, propelled by the increasing complexity of new…
While widely adopted in other industries, continuous manufacturing is only just starting to be explored as a production process by…